Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.
LifeLabs will analyze patient samples for genetic variations that affect drug response, and will use GenXys' software to inform treatment decisions.
An analysis of six "Implementing Genomics in Practice" (IGNITE) consortium network projects pointed to three main challenges in implementing genomic medicine.
The arrangement will allow Illumina to market and promote Kailos' research solutions for pharmacogenetic target enrichment.
The number of institutions offering clinical exome or genome tests to healthy individuals keeps increasing, but the practice remains controversial among medical experts.
Genelex is hoping that a recently published randomized-controlled trial will help it get on better footing with Medicare.
Geneticure has raised around $1.1 million to fund the study, which may very well be the largest prospective RCT for personalization of high blood pressure treatment.
The Canadian company recently published results of a study demonstrating the utility of its pharmacogenomic testing and decision support platform.
The Pharmacogenomics Clinical Annotation Tool interprets variants from sequencing or genotyping tests and generates a report to inform prescribing decisions.
A new PGen study reports that nearly 6 percent of consumers made changes to their prescription medication based on pharmacogenomic testing.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.